[The division and the investments in clinical research of various blood derivative products at Octapharma].
Octapharma France SAS. laurent.de-narbonne@octapharma.com
L
L
de Narbonne
T
T
Grivel
D035843:Biomedical Research; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002469:Cell Separation; D017326:Clinical Trials, Phase III as Topic; D004345:Drug Industry; D005602:France; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D001779:Blood Coagulation Factors; D007155:Immunologic Factors